Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)
China
· Delayed Price · Currency is CNY 31.02
+0.60 (1.97%)
At close: Mar 10, 2026
SHE:002940 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 602.24 | 697.38 | 859.75 | 735.47 | 688.91 | 854.07 | Upgrade
|
| Trading Asset Securities | 187.3 | 36.04 | 10 | 69.3 | 59.6 | - | Upgrade
|
| Cash & Short-Term Investments | 789.54 | 733.42 | 869.75 | 804.76 | 748.51 | 854.07 | Upgrade
|
| Cash Growth | -11.77% | -15.68% | 8.08% | 7.52% | -12.36% | 36.05% | Upgrade
|
| Accounts Receivable | 183.01 | 234.32 | 244.86 | 295.51 | 301.32 | 259.8 | Upgrade
|
| Other Receivables | 1.33 | 9.85 | 21.45 | 6.77 | 17.27 | 11.44 | Upgrade
|
| Receivables | 184.34 | 244.18 | 266.31 | 302.28 | 318.59 | 271.24 | Upgrade
|
| Inventory | 467.95 | 503.79 | 393.44 | 293.23 | 299.6 | 263 | Upgrade
|
| Other Current Assets | 19.98 | 17.48 | 32.43 | 51.69 | 9.25 | 5.09 | Upgrade
|
| Total Current Assets | 1,462 | 1,499 | 1,562 | 1,452 | 1,376 | 1,393 | Upgrade
|
| Property, Plant & Equipment | 593.49 | 603.86 | 615.8 | 445.7 | 474.63 | 389.51 | Upgrade
|
| Long-Term Investments | 306.15 | 304.7 | 301.41 | 302.15 | 147.34 | 94.99 | Upgrade
|
| Goodwill | 312.94 | 312.94 | 312.94 | 21.98 | 21.98 | - | Upgrade
|
| Other Intangible Assets | 126.07 | 133.55 | 139.14 | 38.78 | 40.05 | 36.88 | Upgrade
|
| Long-Term Deferred Tax Assets | 46.07 | 50.06 | 32.77 | 22.44 | 20.65 | 22.88 | Upgrade
|
| Long-Term Deferred Charges | 54.32 | 49.48 | 35.06 | 0.98 | 1.6 | 1.57 | Upgrade
|
| Other Long-Term Assets | 20.66 | 21.07 | 20.95 | 312.09 | 1.36 | 1.53 | Upgrade
|
| Total Assets | 2,922 | 2,975 | 3,020 | 2,596 | 2,084 | 1,941 | Upgrade
|
| Accounts Payable | 449.84 | 485.45 | 402.49 | 320.45 | 335.97 | 322.73 | Upgrade
|
| Accrued Expenses | 33.35 | 120.24 | 130.41 | 220.56 | 218.67 | 182.3 | Upgrade
|
| Short-Term Debt | 137.82 | 163.37 | 134.9 | 171.94 | 1.76 | 11.77 | Upgrade
|
| Current Portion of Long-Term Debt | 32.22 | 20.21 | 30.4 | 25.02 | - | - | Upgrade
|
| Current Portion of Leases | - | - | 0.26 | - | - | - | Upgrade
|
| Current Income Taxes Payable | 13.71 | 5.57 | 9.34 | - | 2.88 | 9.18 | Upgrade
|
| Current Unearned Revenue | 9.41 | 32.31 | 18.72 | 41.67 | 31.9 | 17.47 | Upgrade
|
| Other Current Liabilities | 92.08 | 16.39 | 5.45 | 8.95 | 4.1 | 1.74 | Upgrade
|
| Total Current Liabilities | 768.42 | 843.54 | 731.97 | 788.59 | 595.29 | 545.19 | Upgrade
|
| Long-Term Debt | 298.35 | 303.5 | 423.95 | 150 | - | - | Upgrade
|
| Long-Term Unearned Revenue | 17.8 | 16.78 | 17.85 | 9.73 | 13.3 | 17.59 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 11.24 | 12.29 | 13.95 | 1.6 | 0.06 | - | Upgrade
|
| Total Liabilities | 1,096 | 1,176 | 1,188 | 949.93 | 608.64 | 562.78 | Upgrade
|
| Common Stock | 201.73 | 201.73 | 201.73 | 139.12 | 95.95 | 95.95 | Upgrade
|
| Additional Paid-In Capital | 700.48 | 684.01 | 723.84 | 782.91 | 824.87 | 816.25 | Upgrade
|
| Retained Earnings | 766.08 | 712.9 | 674.51 | 577.87 | 478.74 | 405.84 | Upgrade
|
| Treasury Stock | -84.1 | -74.5 | -20.12 | - | -63.34 | - | Upgrade
|
| Comprehensive Income & Other | 9.71 | 6.4 | 6.25 | 2.75 | 2.64 | 0.84 | Upgrade
|
| Total Common Equity | 1,594 | 1,531 | 1,586 | 1,503 | 1,339 | 1,319 | Upgrade
|
| Minority Interest | 231.84 | 267.87 | 246.07 | 143.5 | 136.08 | 59.09 | Upgrade
|
| Shareholders' Equity | 1,826 | 1,798 | 1,832 | 1,646 | 1,475 | 1,378 | Upgrade
|
| Total Liabilities & Equity | 2,922 | 2,975 | 3,020 | 2,596 | 2,084 | 1,941 | Upgrade
|
| Total Debt | 468.38 | 487.08 | 589.52 | 346.96 | 1.76 | 11.77 | Upgrade
|
| Net Cash (Debt) | 321.16 | 246.34 | 280.23 | 457.8 | 746.75 | 842.3 | Upgrade
|
| Net Cash Growth | -2.60% | -12.10% | -38.79% | -38.69% | -11.34% | 34.55% | Upgrade
|
| Net Cash Per Share | 1.60 | 1.23 | 1.40 | 2.30 | 3.74 | 4.43 | Upgrade
|
| Filing Date Shares Outstanding | 196.11 | 196.89 | 199.71 | 197.4 | 197.4 | 201.73 | Upgrade
|
| Total Common Shares Outstanding | 196.11 | 196.89 | 199.71 | 197.4 | 197.4 | 201.73 | Upgrade
|
| Working Capital | 693.4 | 655.33 | 829.96 | 663.37 | 780.67 | 848.21 | Upgrade
|
| Book Value Per Share | 8.13 | 7.77 | 7.94 | 7.61 | 6.78 | 6.54 | Upgrade
|
| Tangible Book Value | 1,155 | 1,084 | 1,134 | 1,442 | 1,277 | 1,282 | Upgrade
|
| Tangible Book Value Per Share | 5.89 | 5.51 | 5.68 | 7.30 | 6.47 | 6.36 | Upgrade
|
| Buildings | - | 447.5 | 435.42 | 314.48 | 319.46 | 196.09 | Upgrade
|
| Machinery | - | 640.01 | 628.95 | 467.67 | 439.73 | 344.29 | Upgrade
|
| Construction In Progress | - | 49.6 | 22.52 | 25.33 | 29.94 | 113.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.